Literature DB >> 16033082

Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).

I Mylonas1, U Jeschke, N Shabani, C Kuhn, S Kriegel, M S Kupka, K Friese.   

Abstract

Human endometrium expresses estrogen (ER) and progesterone (PR) receptors, which are related to autocrine and paracrine processes that respond to estrogen and progesterone. The ER and PR expression and distribution pattern may play an important role in endometrial function and pathogenesis. The aim of this study was to evaluate the distribution pattern of ER-alpha, ER-beta and PR in normal (n=15) and malignant (n=11) human endometrial tissue. Commercially available monoclonal antibodies against ER-alpha, ER-beta and PR were used. The distribution of the steroid receptors was evaluated using the IRS-score and the Mann-Whitney rank-sum test was used to compare the means. Correlation was assessed with the Spearman factor and linear regression analysis. ER-alpha, ER-beta and PR declined significantly (p <0.05) in normal glandular epithelium from proliferative to late secretory phase, although the staining intensity of ER-beta was lower than that of ER-alpha. ER-alpha, ER-beta and PR were also expressed in malignant endometrial tissue. A significant correlation by regression analysis of ER-alpha and ER-beta was demonstrated, showing a dependence in the expression of these steroid receptors. The ER-alpha/ER-beta ratio decreased significantly from normal to malignant endometrial tissue (p<0.05), while the ER-beta/ER-alpha ratio showed statistical differences within normal endometrial tissue. These results showed the presence of steroid receptors in normal and malignant human endometrium, indicating a significant role in endometrial physiology and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033082

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten+/- mice.

Authors:  Wei Yu; Mark Cline; Larry G Maxwell; David Berrigan; Gustavo Rodriguez; Anni Warri; Leena Hilakivi-Clarke
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

2.  Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.

Authors:  Ashley S Felix; Roslyn A Stone; Mamatha Chivukula; Robert Bowser; Anil V Parwani; Faina Linkov; Robert P Edwards; Joel L Weissfeld
Journal:  Int J Cancer       Date:  2012-01-03       Impact factor: 7.396

3.  Expression of ERα and PR in Various Morphological Patterns of Abnormal Uterine Bleeding-Endometrial causes in Reproductive Age Group.

Authors:  Priya Singh; Pallavi Singh; Amrita Chaurasia; Vishal Dhingra; Vatsala Misra
Journal:  J Clin Diagn Res       Date:  2016-08-01

4.  Interstitial Cajal-like cells (ICLC) as steroid hormone sensors in human myometrium: immunocytochemical approach.

Authors:  D Cretoiu; Sanda M Ciontea; L M Popescu; Laura Ceafalan; Carmen Ardeleanu
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

5.  Chloride channel-3 promotes tumor metastasis by regulating membrane ruffling and is associated with poor survival.

Authors:  Bin Xu; Xiaobao Jin; Ling Min; Qin Li; Lulu Deng; Hui Wu; Guixian Lin; Lixin Chen; Haifeng Zhang; Chunmei Li; Liwei Wang; Jiayong Zhu; Weizhang Wang; Fujiang Chu; Juan Shen; Hongzhi Li; Jianwen Mao
Journal:  Oncotarget       Date:  2015-02-10

6.  Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only.

Authors:  Linda Hertlein; Johanna Rath; Christine Zeder-Göss; Sophie Fürst; Daniela Bayer; Fabian Trillsch; Sven Mahner; Alexander Burges; Udo Jeschke
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.